News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

$900 Point-of-Care DNA Nanopore Sequencer May Hit Market in Next 12 Months

Even small clinical pathology laboratories could afford this  new miniaturized gene sequencer

Is the profession of pathology  and clinical laboratory medicine ready to deal with point-of-care DNA sequencing technologies? A company in the United Kingdom says that, as early as next year, it can bring a portable high-throughput unit to market that will sell for around US $900.

Researchers at Oxford Nanopore Technologies Ltd. (ON) have developed new-generation sequencing technology that uses nanopores to deliver ultra-long, read-length, single molecule sequence data, the company stated in a press release. And it does this with competitive accuracy on a high-throughput electronic platform. (more…)

;